Sanofi Pasteur has ended its vaccine joint venture (JV) with MSD (known as Merck & Co in the US and Canada), Sanofi Pasteur MSD (SPMSD).

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Both companies will integrate their respective vaccines business in Europe into their operations and separately pursue their own vaccine strategies within the region.

The project was announced in March last year and since then it has been managed in an open dialogue with the SPMSD employees, unions and relevant external stakeholders.

Sanofi Pasteur and MSD had jointly stated: “After carefully considering our individual strategic priorities, alongside the economic and regulatory environments for vaccine operations in the European Union, we have mutually agreed that it is in our best interests to manage our vaccine product portfolios independently.

“We believe that focusing our efforts on opportunities unique to our respective companies will better position us to drive growth, execute in a more efficient manner and optimise vaccine coverage.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
"Both companies will integrate their respective vaccines business in Europe into their operations and separately pursue their own vaccine strategies within the region."

Following the completion of the JV, each company will now be able to define its own vaccines strategy.

Sanofi announced in November 2015 that it would reshape its portfolio as part of its Strategic Roadmap 2020.

Sanofi Pasteur is the vaccines division of Sanofi and provides more than one billion doses of vaccine each year.

Owned on a 50/50 basis by Sanofi Pasteur and MSD, the Sanofi Pasteur MSD JV was created in 1994 to develop and commercialise vaccines originating from both companies’ pipelines to promote public health in 19 European countries.

Image: Sanofi Pasteur is the vaccines division of Sanofi. Photo: courtesy of Sanofi.